CellCarta

As a global contract research organization (CRO) laboratory in the biopharmaceutical industry, CellCarta offers a wide range of biomarker platforms and services. We collaborate with you to address the most complex scientific testing needs, providing customized biomarker testing solutions to further unlock the immense potential of precision medicine. CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials, utilizing its integrated analytical platforms in immunology, histopathology, proteomics, and genomics, along with related specimen collection and logistics services. The company operates globally, with 10 branches located in Canada, the United States, Belgium, Australia, and China.